The development of a generic formulation requires replicating a reference formulation in both content and conduct. This includes mimicking the release rate of the active as characteristic of the formulation. IVRT (in vitro Release Testing) provides a convenient and reliable tool to measure the release rate of topical formulations and hence, is uniquely qualified to establish bioequivalence.